| By PR Newswire | Article Rating: |
|
| February 13, 2013 05:59 PM EST | Reads: |
296 |
MCLEAN, Va., Feb. 13, 2013 /PRNewswire-USNewswire/ -- Meth addiction is a worldwide epidemic of unimaginable proportions, with an estimated 15,000 deaths in the United States alone last year. States with prescription-only pseudoephedrine laws show a decrease in meth labs, according to a Government Accountability Office (GAO) report released today.
Allergy & Asthma Network Mothers of Asthmatics (AANMA) supports legislation to return pseudoephedrine (PSE) medications to the prescription-only status they held prior to 1976. PSE, a sinus decongestant, is not included as an appropriate asthma medication in the National Institutes of Health Guidelines for the Diagnosis and Management of Asthma.
"Pseudoephedrine hydrochloride, which is the key ingredient for the manufacturing of methamphetamines, does not serve a significant role in the care of patients who suffer from allergic or non-allergic rhinitis," says Stuart W. Stoloff, MD, FAAAAI, FAAFP, clinical professor of family and community medicine, University of Nevada School of Medicine. "Other medications including saline offer a safer option when treating nasal congestion whether it be associated with the common cold, allergic, or non-allergic rhinitis. Given the enhanced safety profile of these other medications, there is no role for pseudoephedrine hydrochloride to be readily available to patients as a 'behind the counter' medication that does not require a prescription written by a qualified medical practitioner."
In 28 years, AANMA has never heard from asthma and allergy patients who rely on non-prescription oral decongestants for their condition.
The most recent data from law enforcement indicates that diversion of legally produced PSE to methamphetamine production in small, toxic "one-pot" labs continues to rise everywhere except in the two states (Oregon in 2006, Mississippi in 2010) where a prescription is now required. Thus, it seems almost ludicrous not to take advantage of an easy solution to the meth lab problem that requires only the stroke of a pen for implementation.
Preventing the diversion of PSE to the manufacture of methamphetamine is far more urgent and vital to the public interest than continued availability of any particular remedy for the common cold.
About AANMA
Allergy & Asthma Network Mothers of Asthmatics (AANMA) is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. AANMA specializes in sharing family-friendly, medically accurate information through its award-winning publications Allergy & Asthma Today magazine and The MA Report newsletter, its web site at www.aanma.org and numerous community outreach programs. Follow AANMA on Facebook at facebook.com/AANMA and on Twitter at twitter.com/AANMA.
Contact: Gary Fitzgerald
Allergy & Asthma Network
Mothers of Asthmatics
703-641-9595
gfitzgerald@aanma.org
SOURCE Allergy & Asthma Network Mothers of Asthmatics
Published February 13, 2013 Reads 296
Copyright © 2013 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
- Cloud People: A Who's Who of Cloud Computing
- Cloud Expo New York Speaker Profile: Dave Linthicum – Cloud Technology Partners
- Windows Azure IaaS Reaches General Availability
- Enterasys Spotlights SDN's Impact on Traditional Networking in Upcoming Webinar
- New Relic Q1 2013 Blazes Past Growth Targets and Reaches 40,000 Active Customer Accounts
- NASA's Twitter Account Wins Back-To-Back Shorty Awards
- Big Data Isn’t About the Database, It’s About the Application
- BEA Updates WebLogic SOA Portal for Web 2.0 Era
- Upcoming Bloomberg BNA Webinar Focuses on COPPA Compliance
- Cloud Expo New York | Danger Ahead: Why File Sync Is NOT Endpoint Backup
- Cloud Expo New York: Basics of SSD Technology and Its Use in Cloud
- Symphony EYC Appoints New Account Manager to Drive Global Opportunities
- Cloud People: A Who's Who of Cloud Computing
- Cloud Expo New York Speaker Profile: Dave Linthicum – Cloud Technology Partners
- Cloud Expo New York: How to Use Google Apps Script
- Windows Azure IaaS Reaches General Availability
- Enterasys Spotlights SDN's Impact on Traditional Networking in Upcoming Webinar
- Upcoming Domino's Pizza Investor Events
- New Relic Q1 2013 Blazes Past Growth Targets and Reaches 40,000 Active Customer Accounts
- Scripps Networks Interactive’s Popular Lifestyle Shows from HGTV, DIY Network, Food Network, Cooking Channel and Travel Channel Coming to Prime Instant Video and Amazon Instant Video
- Rackspace Hosting Named “Platinum Plus Sponsor” of Cloud Expo New York
- RetailMeNot Shoppers Trend Report: While Over 8 in 10 U.S. Residents Cite Affordability as Their Top Vacation Priority, a Majority (58%) Could Waste Hundreds of Dollars by Booking Travel a la Carte
- Small Cancers, Big Data, and a Life Examined
- NASA's Twitter Account Wins Back-To-Back Shorty Awards
- The Top 150 Players in Cloud Computing
- Who Are The All-Time Heroes of i-Technology?
- Where Are RIA Technologies Headed in 2008?
- Success, Arrogance, Rise and Fall
- AJAX World RIA Conference & Expo Kicks Off in New York City
- Personal Branding Checklist
- The Top 250 Players in the Cloud Computing Ecosystem
- i-Technology Viewpoint: Attack of the Blogs
- Exclusive Q&A with Jeff Haynie, Co-Founder & CEO, Appcelerator
- Web 2.0 News and Wrapping Up "Real-World AJAX" Seminar
- Passing Parameters to Flex That Works
- i-Technology Viewpoint: It's Time to Take the Quotation Marks Off "Web 2.0"






























